Trial Profile
Safety and Efficacy of 8mg Once-daily Versus 4mg Twice-daily Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH ; 12-week, Double-blind, Randomized, Comparison, Multi-center Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms SILVER
- Sponsors JW Pharmaceutical
- 11 Feb 2014 Results published in the Urology.
- 29 Mar 2012 Actual patients number is 424 as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.